BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35861797)

  • 1. Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial.
    Magnuson EA; Chinnakondepalli K; Vilain K; Serruys PW; Sabik JF; Kappetein AP; Stone GW; Cohen DJ;
    Circ Cardiovasc Interv; 2022 Jul; 15(7):e011981. PubMed ID: 35861797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
    Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ;
    Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
    Huang X; Redfors B; Chen S; Liu Y; Ben-Yehuda O; Puskas JD; Kandzari DE; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1144-1151. PubMed ID: 30596978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
    Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
    Cohen DJ; Lavelle TA; Van Hout B; Li H; Lei Y; Robertus K; Pinto D; Magnuson EA; Mcgarry TF; Lucas SK; Horwitz PA; Henry CA; Serruys PW; Mohr FW; Kappetein AP
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):198-209. PubMed ID: 21542113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program.
    Reynolds MR; Gong T; Li S; Herzog CA; Charytan DM
    J Am Heart Assoc; 2021 Apr; 10(7):e019391. PubMed ID: 33787323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Gaba P; Sabik JF; Murphy SA; Bellavia A; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Sabatine MS; Stone GW; Bergmark BA
    Circulation; 2024 Apr; 149(17):1328-1338. PubMed ID: 38465592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP;
    N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
    Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP
    J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.